2025-02-04 - Analysis Report
## Merck & Co Inc (MRK) Stock Review

**0. Key Figures Summary:**

* **Cumulative Return (MRK):** 63.14%
* **Cumulative Return (VOO):** 119.91%
* **Return Difference (MRK vs VOO):** -56.8%
* **Relative Divergence:** 6.7% (indicates MRK's underperformance relative to historical data)
* **Current Price:** $98.82
* **RSI:** 48.63
* **PPO:** 0.13
* **Expected Return (vs S&P 500):** 95.9% (long-term, >2 years)


**1. Performance Comparison and Company Overview:**

Merck & Co Inc (MRK) is a leading global healthcare company.  While MRK showed a cumulative return of 63.14%, it significantly underperformed the S&P 500 (VOO) which had a return of 119.91%.  The difference of -56.8% places MRK's performance in the 6.7th percentile of its historical performance relative to the S&P 500. This suggests that MRK's recent underperformance is not entirely unprecedented, but still sits below average compared to its historical performance relative to the market.

The provided Alpha and Beta analysis shows fluctuating performance relative to the market (Beta) and varying levels of outperformance (Alpha) over different time periods.  High Betas indicate higher volatility than the market.  Noticeably, the MDD (Maximum Drawdown) fluctuates substantially, highlighting periods of significant risk.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -2.0% | 11.8% | -30.0% | -0.1 | 111.1 |
| 2016-2018  | 46.0% | 11.8% | 28.0% | 0.5 | 155.5 |
| 2017-2019  | 44.0% | 11.8% | 14.0% | 0.3 | 190.2 |
| 2018-2020  | 32.0% | 9.4% | 5.0% | 0.2 | 176.5 |
| 2019-2021  | 3.0% | 14.3% | -68.0% | 0.2 | 179.6 |
| 2020-2022  | 47.0% | 14.3% | 38.0% | 0.2 | 268.3 |
| 2021-2023  | 55.0% | 14.3% | 32.0% | 0.3 | 271.0 |
| 2022-2024  | 21.0% | 9.5% | -12.0% | 0.3 | 254.1 |
| 2023-2025  | -23.0% | 9.5% | -84.0% | 0.2 | 252.4 |


**2. Recent Price Movements:**

* **Closing Price:** $98.82
* **Last Market Price:** $99.76 (+$0.94 increase from previous close)
* **5-day Moving Average:** $98.29
* **20-day Moving Average:** $98.65
* **60-day Moving Average:** $99.31

The price is slightly above the 5 and 20-day moving averages, suggesting recent upward momentum, but below the 60-day MA, indicating a potential short-term trend reversal. The recent price jump suggests a potentially positive short-term outlook.


**3. Technical Indicators:**

* **RSI (48.63):**  Near the neutral level (50), suggesting neither overbought nor oversold conditions.
* **PPO (0.13):**  Positive, indicating a bullish trend.
* **Recent Relative Divergence (+6.7):**  Suggests short-term upward momentum.

The recent price increase of $0.94 indicates a short-term price jump.  This needs to be carefully considered.  A larger increase might need further investigation regarding potential news or market events driving the unexpected spike. The high expected return of 95.9% (over S&P 500) for long-term investment needs careful interpretation, possibly reflecting past performance and not guaranteeing future success.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|----------------|
| 2024-11-06 | 1.25  | $16.66 B       |
| 2024-08-05 | 2.15  | $16.11 B       |
| 2024-05-03 | 1.88  | $15.78 B       |
| 2023-11-03 | 1.87  | $15.96 B       |
| 2024-11-06 | 1.87  | $15.96 B       |

There appears to be a duplicated entry for 2024-11-06.  EPS and revenue show some fluctuation.  A more detailed analysis, including comparing to previous years' performance,  is needed to draw meaningful conclusions.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-09-30 | $16.66B    | 75.51%        |
| 2024-06-30 | $16.11B    | 76.76%        |
| 2024-03-31 | $15.78B    | 77.56%        |
| 2023-12-31 | $14.63B    | 73.26%        |
| 2023-09-30 | $15.96B    | 73.29%        |

Revenue shows a generally increasing trend, although with some quarter-to-quarter variation.  Profit margins are consistently high, but have shown some slight decrease recently.

**Capital and Profitability:**

| Quarter | Equity      | ROE           |
|---------|-------------|---------------|
| 2024-09-30 | $44.50B    | 7.09%         |
| 2024-06-30 | $43.58B    | 12.52%        |
| 2024-03-31 | $40.36B    | 11.80%        |
| 2023-12-31 | $37.58B    | -3.26%        |
| 2023-09-30 | $41.25B    | 11.50%        |

Equity shows growth, but ROE (Return on Equity) fluctuates significantly, indicating variations in profitability relative to shareholder equity.  The negative ROE in 2023-12-31 warrants further investigation.


**6. Overall Analysis:**

MRK has shown inconsistent performance relative to the S&P 500, with recent underperformance. While technical indicators suggest short-term bullish potential, the long-term outlook requires further analysis.  Earnings show some fluctuation, and financial information indicates strong profitability but variability in ROE.  A deeper dive into the reasons for the fluctuating performance, the duplicated earnings data, and the negative ROE is necessary before making any investment decisions.  The provided expected return needs further justification and should be treated with caution.  Additional factors, such as industry trends and competitive landscape, should be considered for a comprehensive analysis.
